Rice Hall James & Associates’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-423,249
Closed -$6.5M 323
2021
Q4
$6.5M Buy
423,249
+133,411
+46% +$1.76M 0.23% 85
2021
Q3
$2.52M Buy
289,838
+138,802
+92% +$1.27M 0.09% 167
2021
Q2
$1.54M Buy
+151,036
New +$1.59M 0.05% 234

Other funds holding NPTN

Rice Hall James & Associates's NPTN Position: Q1 2022 in Review

Rice Hall James & Associates sold out of NEOPHOTONICS CORP (NPTN) in Q1 2022, closing a stake of 423,249 shares — an estimated $6.5M sold.

Rice Hall James & Associates first reported a position in NPTN in Q2 2021 and held it in 3 quarters. The position peaked at $6.5M in Q4 2021. 143 funds tracked by Wall St. Rank hold NPTN as of Q1 2022.

  • Rice Hall James & Associates reported no remaining NEOPHOTONICS CORP position as of Q1 2022 after selling out during the quarter.
  • Rice Hall James & Associates sold 423,249 NEOPHOTONICS CORP shares in Q1 2022, an estimated $6.5M.
  • Rice Hall James & Associates first reported a position in NEOPHOTONICS CORP in Q2 2021 and held it in 3 quarters.
  • Rice Hall James & Associates's NEOPHOTONICS CORP position peaked at $6.5M in Q4 2021.
  • 143 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2022.

Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.